Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.5T | 1.4T | 1.7T | 1.5T |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 185.6B | 195.7B | 184.3B | 390.2B |
| Other operating expenses | 19.0B | 19.2B | 15.6B | 20.1B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 656.8B | 784.1B | 956.2B | 526.4B |
| Tax provision | 124.3B | 150.7B | 187.4B | 100.1B |
| Net income | 532.5B | 633.4B | 768.8B | 426.3B |
| Basic EPS | 45 | — | — | — |
| Diluted EPS | 45 | — | — | — |
| Basic average shares | 11.7B | — | — | — |
| Diluted average shares | 11.7B | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |